Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Johns Hopkins Medicine

US study suggests BMS’ cancer drug could target Parkinson’s-causing protein

US study suggests BMS’ cancer drug could target Parkinson’s-causing protein
p p Read More

The progressive neurodegenerative condition affects more than ten million people worldwide

June 20, 2024 Bristol Myers Squibb, Johns Hopkins Medicine, Lag3, neurodegenerative conditions, News, nivolumab/relatlimab, Opdualag, Parkinson's disease

US study reveals interferon combinations cause lupus symptoms and affect treatment

US study reveals interferon combinations cause lupus symptoms and affect treatment
p p Read More

The autoimmune disease, which affects 1.5 million people in the US, causes the body’s immune system to attack […]

May 15, 2024 antiviral proteins, chronic autoimmune conditions, interferons, Johns Hopkins Medicine, Lupus, News

Johns Hopkins scientists depict molecular pathway to track replication in cancer cells

The findings could potentially lead to new therapies and could stop the growth of cancers

May 8, 2024 anaphase-promoting complex, Cancer, cell cyles, cyclin dependent kinases, Johns Hopkins Medicine, News, Oncology
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy